Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allen, S., Serufilira, A., Bogaerts, J., Van de Perre, P., Nsengumuremyi, F., Lindan, C, Carael, M., Wolf, W., Coates, T., & Hulley, S. (1992). Confidential HIV Testing and Condom Promotion in Africa: Impact on HIV and gonorrhea rates. JAMA, 268, 333–843.
Allen, S., Tice, J., Van de Perre, P., Serufilira, A., Hudes, E., Nsengumuremyi, F., Bogaerts, J., Lindan, C., & Hulley, S. (1992). Effect of serotesting with counseling on condom use and seroconversion among HIV discordant couples in Africa. British Medical Journal, 304, 1605–09.
Alliance for Microbicide Development (2000, November). Microbicide product development: Research overview. Author.
Artz, L., Macaluso, M., Brill, I., Kelaghan, J., Harland, A., Fleenor, M., Robey, L., & Hook, E. W. (2000). Effectiveness of an intervention promoting the female condom to patients at sexually transmitted disease clinics. American Journal of Public Health, 90, 237–244.
Asamoah-Adu, A., Weirs, S., Pappoe, M., Kaulisi, N., Neequaye, A., & Lamptey, P. (1994). Evaluation of a targeted AIDS prevention intervention to increase condom use among prostitutes in Ghana. AIDS, 8, 239–246.
Ashery, R. S., Carson, R. G., Falck, R. S., Siegal, H. A., & Wang, J. (1995). Female condom use among injection drug-and crack cocaine-using women. American Journal of Public Health, 85, 736–737.
Bernstein, G.S., Clark, V., Coulson, A.H., Frezieres, R.G., Kilzet, L. Moyer, D., Nakamura, R.M., & Walsh, T. (1986, July). Use effectiveness of cervical caps. Final report. (Contract No. 1-HD-1-2804). Washington DC: National Institute of Child Health and Human Development.
Bhave, G., Lindan, C. P., Hudes, E. S., Desai, S., Wagle, U., Tripathi, S.P., & Mandel, J.S. (1995). Impact of an intervention on HIV, sexually transmitted diseases, and condom use among commercial sex workers in Bombay, India. AIDS, 9 (suppl 1), S21–S30.
Bird, J.A. (1991). The use of spermicide containing nonoxynol-9 in the prevention of HIV infection. AIDS, 5, 791–796.
Bounds, W. Guillebaud, J., Stewart, L., & Newman, G. B. (1992). Female condom (Femidom). A clinical study of its use-effectiveness and patient acceptability. British Journal of Family Planning, 18, 36–41.
Bounds, W., Guillebaud, J., Stewart, L., & Steele, S. (1988). Female condom (Femshield): A study of its user-acceptability. British Journal of Family Planning, 14, 83–87.
Cabral, R.J., Pulley, L., Artz, L., Johnson, C., Stephens, R., & Macaluso, M. (1999). Women at risk of HIV/STD: Who is receptive to using the female condom? Journal of Sex Education and Therapy, 24, 89–98.
Carey, R. F., Herman, W. A., Retta, S. M., Rinaldi, J. E., Herman B. A., & Athey, T. W. (1992). Effectiveness of latex condoms as a barrier to human immunodeficiency virus-sized particles under conditions of simulated use. Sexually Transmitted Diseases, 19, 230–4.
Cates, W., & Raymond, E. G. (1999). Vaginal Spermicides. In Hatcher, R., Trussell, J., Stewart, F., Cates, W., Stewart, G., Guest, F., Kowal, D. (Eds.), Contraceptive Technologies (pp. 357–369). New York: Ardent Media, Inc.
Cates, W., & Stone, K., M. (1992). Family Planning, sexually transmitted disease, and contraceptive choice: a literature update. Family Planning Perspectives, 24, 75–84.
Cecil, H., Perry, M.J., Seal, D.W., & Pinkerton, S.D. (1998). The female condom: What we have learned thus far. AIDS and Behavior, 2, 241–256.
Centers for Disease Control and Prevention (1993). Update: Barrier protection against HIV infection and other sexually transmitted diseases. MMWR, 42, 589–591, 597.
Centers for Disease Control and Prevention (1997). Update: Trends in AIDS incidence B United States, 1996. MMWR, 46, 861–867.
Centers for Disease Control and Prevention. (1999). HIV/AIDS Surveillance Report, Vol 11(No. 2). Atlanta, GA: Author.
Coggins, C., Blanchard, K., Alvarez, F., Brache, V., Weisberg, E., Kilmarx, P.H., Lacarra, M., Massai, R., Mishell, D., Salvatierra, A., Witwatwongwana, P., Elias, C., & Ellertson, C. (2000, March). Safety and acceptability of Lambda-Carrageenan-containing vaginal microbicide gel PC-503. Paper presented at the Microbicide 2000 meeting, Washington, DC.
Cohen, D., Reardon, K., Alleyne, D., Murthy, S., & Linton, K. (1995). Influencing spermicide use among low-income minority women. Journal of the American Medical Women’s Association, 50, 11–13.
Council for International Organizations of Medical Sciences (1991). International guidelines for ethical review of epidemiological studies. Geneva, Switzerland. Author. Cramer, D. W., Goldman, M.B., Schiff, I., Belisle, S. Albrecht, B., Stadel, B., Gibson, M., Wison, E., Stillman, R., T., & Thompson, I. (1987). The relationship of tubal infertility to barrier method and oral contraceptive use. Journal of the American Medical Association, 257, 2446–2450.
de Vincenzi, I., for the European Study Group on Heterosexual transmission of HIV (1994). A longitudinal study of human immunodeficiency virus transmission by heterosexual partners The New England Journal of Medicine, 331, 341–346.
de Zoysa, I., Elias, C.J., & Bentley, M.E. (1998). Ethical challenges in efficacy trials of vaginal microbicides for HIV prevention. American Journal of Public Health, 88, 571–575.
Diaz, T., Chu, S.Y., Conti, L., Sorvillo, F., Checko, P.J., Hermann, P., Farm, S.A., Frederick, M., Boyd, D., Mokotoff, E., Rietmeijer, C.A., Herr, M., & Samuel, M.C. (1994). Risk behaviors of persons with heterosexually acquired HIV infection in the United States: Results of a multistate surveillance project. Journal of Acquired Immune Deficiency Syndromes, 7, 958–963.
DiClemente, R. J., & Wingood, G. M., (1995). A randomized controlled trial of a community based HIV sexual risk reduction intervention for young adult African-American females. Journal of the American Medical Association, 274, 1271–1276.
D’Oro, L.C., Parazzini, F. Naldi, L., & LaVecchia, C. (1994). Barrier methods of contraception, spermicides, and sexually transmitted diseases: A review. Genitourinary Medicine, 70, 410–417.
Drew, W. L., Blair, M., Miner, R. C, & Conant, M. (1990). Evaluation of the virus permeability of a new condom for women. Sexually Transmitted Diseases, 17, 110–112.
Edelman, D.A., McIntyre, D. L., & Harper, J.A. (1984). A comparative trial of the Today contraceptive sponge and diaphragm. American Journal of Obstetrics and Gynecology, 150, 869–876.
Ehrhardt, A. A., Yingling, S., Zawadzki, R., & Martinez-Ramirez, M. (1992). Prevention of heterosexual transmission of HIV: Barriers for women. Women and Health, 23, 73–89.
Eldridge, G.D. St. Lawrence, J.S., Little, C. E., Shelby, M.C., & Brasfield, T.L. (1995). Barriers to condom use and barrier method preference among low-income African-American women. Women and Health, 23, 73–89. Elias, C., & Coggins, C. (1996). Female controlled methods to prevent sexual transmission of HIV. AIDS, 10, S43–51.
Elias, C., & Heise, L. (1994). Challenges for the development of female-controlled methods to prevent sexual transmission of HIV. AIDS, 8, 1–9.
Farr, G., Gabelnick, H., Sturgen, K., & Dorflinger, L. (1994). Contraceptive efficacy and acceptability of the female condom. American Journal of Public Health, 84, 1960–64.
Feldblum, P.J. & Weir, S.S. (1994). The protective effect of nonoxynol-9 against HIV infection [Letter]. American Journal of Public Health, 84, 1032–1034.
Fontanet, A., Saba, J., Chandelying, V., Sakondhavat, C., Bhiraleus, P., Rugpao, S., Chongsomchai, C, Kiriwat, O, Tovanabutra, S., Dally, L., Lange, J., Rojanapithayakorn, W. (1998). Protection against sexually transmitted diseases by granting sex workers in Thailand the choice of using the male or female condom: results from a randomized controlled trial. AIDS, 12, 1851–1859.
Ford, N., and Mathie, E. (1993). The acceptability and experience of the female condom, Femidom, among family planning clinic attenders. British Journal of Family Planning, 19, 187–192.
Gil, V.E., (1995). The new female condom: Attitudes and opinions of low income Puerto Rican women at risk for HIV/AIDS. Qualitative Health Research, 5, 178–203.
Gollub, E.L., French, P., Loundou, A., Latka, M., Rogers, C., & Stein, Z. (2000). A randomized trial of hierarchical counseling in a short, clinic-based intervention to reduce the risk of sexually transmitted diseases in women. AIDS, 14, 1249–1255.
Gollub, E.L., Stein, Z., and El-Sadr, W. (1995). Short-term acceptability of the female condom among staff and patients at a New York City hospital. Family Planning Perspectives, 27, 155–158.
Grinstead, J.A., Faigeles, B., Binson, D., & Eversley, R. (1993). Sexual risk for human immunodeficiency virus infection among women in high-risk cities. Family Planning Perspectives, 25, 252–256,277.
Grosskurth, H., Mosha, F., Todd, J., Mwijarubi, E., Klokke, A., Senkoro, K., Mayaud, P., Changalucha, J., Nicoll, A., ka-Gina, G., Newell, J., Mugeye, K., Mabey, D., & Hayes, R. (1995). Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomized control trial. Lancet, 346, 530–536.
Hammett, T., Norton, G., Mason, T., Mayer, K., Robles, R., Feudo, R., & Seage, G. (2000, March). Drug-involved women’s user perspective on microbicides. Paper presented at the Microbicides 2000 meeting, Washington, DC.
Haney, D. (1996, May 20). Associated Press News Release.
Hooton, T.M., Hillier, S., Johnson, C., Roberts, P.L., & Stamm, W.E., (1991). Esherchia coli bacteriuria and contraceptive method. Journal of the American Medical Association, 245, 64–69
Howe, J.E., Minkoff, H.L., & Duerr, A. C. (1994). Contraceptives and HIV. AIDS, 8, 861–871.
Jivasak-Apimas, S. (1991). Acceptability of the vaginal sheath (Femshield) in Thai couples. Contraception, 44, 183–190.
Joint United Nations Programme on HIV/AIDS [UNAIDS] (1998, June). Report on Global HIV/AIDS Epidemic. Geneva, Switzerland: Author.
Joint United Nations Programme on HIV/AIDS [UNAIDS] (1998, December). AIDS Epidemic Update. Geneva, Switzerland: Author.
Judson, F.N., Ehret, J.M., Bodin, G.F., Levin, M. J., & Reitmeijer, A.M. (1989). In vitro evaluations of condoms with and without nonoxynol-9 as physical and chemical barriers against Chlamydia trachomatis, herpes simplex virus 2 and human immunodeficiency virus. Sexually Transmitted Diseases, 16, 51–56.
Kalichman, S.C., Williams, E., & Nachimson, D. (1999). Brief behavioural skills building intervention for female controlled methods of STD-HIV prevention: outcomes of a randomized clinical field trial. International Journal of STD and AIDS, 10, 174–181.
Kamb, M.L., Fishbein, M., Douglas, J.M., Rhodes, F., Rogers, J., Bolan, G., Zenilman, J., Hoxworth, T., Malotte, K., Iatesta, M., Kent, C., Lentz, A., Graziano, S., Byers, R.H., & Peterman, T.A., for the Project RESPECT Study Group. (1998). Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized control trial. Journal of the American Medical Association, 280, 1161–7.
Kamenga, M., Ryder, R.W., Jingu, M., Mbuyi, N., Mbu, L., Behets, F., Brown, C., & Heyward WL. (1991). Evidence of marked sexual behavior change associated with low HIV-1 seroconversion in 149 married couples with discordant HIV-1 serostatus: experience at an HIV counselling center in Zaire. AIDS, 5, 61–67.
Kelaghan, J., Rubin, G.L., Ory, H.W., & Layde, P. M. (1982). Barrier-method contraceptives and pelvic inflammatory disease. Journal of the American Medical Association, 248, 185.
Kelly, J., A., Murphy, D., A., Washington, C., D., Wilson, T., S., Koob, J., J., Davis, D., R., Ledezma, G., & Davantes, B. (1994). The effects of HIV/AIDS intervention groups for high-risk women in urban clinics. American Journal of Public Health, 84, 1918–1922.
Klebanoff, S. J., Hillier, S.L., Eschenbach, D.S., & Waltersdorph, S.M. (1991). Control of the microbial flora of the vagina by H2O2-generating lactobacilli. Journal of Infectious Diseases, 164, 94–100.
Klein, H., Eber, M., Crosby, H., Welka, D.A., & Hoffman, J.A. (1999). The acceptability of the female condom among substance-using women in Washington, DC. Women and Health, 29, 97–114.
Kost, K., & Forrest, J. (1992). American women’s sexual behavior & exposure to risk of sexually transmitted diseases. Family Planning Perspectives, 24, 244–254.
Kreiss, J., Ngugi, E., Holmes, K., NdinyaAchola, J., Waiyaki, P., Roberts, P.L., Ruminjo, I., Sajabi, R., Kimata, J., Fleming, T.R., Anzala, A., Holton, D., & Plummer, F. (1992). Efficacy of nonoxynol-9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. Journal of the American Medical Association, 268, 477–482.
Laga, M., Alary, M., Nzila, N., Manoka, A.T., Tuliza, M., Behets, F., Goeman, J., St Louis, M., & Piot, P. (1994). Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers. Lancet, 344, 246–248.
Laga, M., Manoka, A., Kivuvu, M., Malele, B., Tuliza, M., Nzila, N., Goeman, J., Behets, F., Batter, V., Alary, M., Heyward, W.L., Ryder, R.W., & Piot, P. (1993). Non-ulcerative STD as risk factors for HIV infection in women: Results from a cohort study. AIDS. 7, 95–102.
Latka., M., Gollub, E., French, P., Stein, Z. (2000). Male and female condom use among women after counseling in a risk reduction hierarchy for STD prevention. Sexually Transmitted Diseases, 27, 431–437.
Leeper, M. A., & Conrady, M. (1989). Preliminary evaluationof REALITY, a condom for women to wear. Advances in Contraception, 5, 229–235.
Louv, W.C., Austin, H., Alexander, W.J., Stagno, S., & Cheeks, J.A. (1988). A clinical trial of nonoxynol-9 for preventing gonococcal and chlamydial infections. Journal of Infectious Diseases, 158, 518–523.
Madrigal, J., Schifter, J., & Feldblum, P.J. (1998). Female condom acceptability among sex workers in Costa Rica. AIDS Education and Prevention, 10, 105–113.
Malkovsky, M., Newell, A., & Dalgleish, A.G. (1988). Inactivation of HIV by nonoxynol-9. Lancet, 1, 645.
Martin, H.L., Stevens, C.E., Richardson, B.A., Rugamba, D., Nyange, P.M., Mandaliya, K., Ndinya-Achola, J., & Kreis, J.K. (1997). Safety of a nonoxynol-9 vaginal gel in Kenyan prostitutes. Sexually Transmitted Diseases, 24, 279–283.
Miller, C.J., Alexander, N.J., Gertie, A., Hendrickx, A.G., & Marx, P.A. (1992). The effect of contraceptives containing nonoxynol-9 on the genital transmission of simian immunodeficiency virus in rhesus macaques. Fertility and Sterility, 57, 1126–1128.
Miller, C.J., Alexander, N.J., Sutjipto, S., Joye, S.M., Hendrickx, A.G., Jennings, M., & Marx, P.A. (1990). Effect of virus dose and Nonoxynol-9 on the genital transmission of ZIV in rhesus macaques. Journal of Medical Primatology, 19, 401–409.
Miller, C., Alexander, N.J., Vogel, P., Anderson, J., & Marx, P.A.. (1992). Mechanisms of genital transmission of ZIV: A hypothesis based on transmission studies and the location of ZIV in the genital tract of chronically infected females. Journal of Medical Primatology, 21, 64–68.
Miller, L.C., Murphy, ST., Clark, L.F., & Moore, J. (2001). Hierarchical messages for introducing multiple HIV prevention options: Promise and pitfalls. Unpublised manuscript.
Moon, M.W., Mbizvo, M.T., Heiman, J.E., Chirenje, Z.M., Khumalo-Sakutukwa, G., Mwale, M., Nyamapfeni, P., & Padian, N. (2000). Evaluation of the feasibility and acceptability of vaginal microbicides for the prevention of HFV/STI in Zimbabwe. National Academies of Practive Forum, 2, 135–139.
Murphy, S. T., Miller, C. L., Moore, J., & Clark, L.F. (2000). Preaching to the choir: Preference for female-controlled methods of HIV and Sexually Transmitted Disease Prevention. American Journal of Public Health, 90, 1135–1137
Musabe, E., Morrison, C.S., Sunkutu, M.R., & Wong, E. L. (1998). Long-term use of the female condom among couples at high risk of human immunodeficiency virus infection in Zambia. Sexually Transmitted Diseases, 25, 1–5.
National Center for Health Statistics. (1997). Health B United States 1996–1997 and Injury Chartbook. (DHHS Publication No. PHS 97-1232). Hyattsville, MD: Superintendent of Documents.
Nelson, K.E., Celentano, D.D., Eiumtrakol, S., Hoover, D.R., Beyrer, C., Suprasert, S., Kuntolbutra, S., & Khamboonruang, C. (1996). Changes in sexual behavior and a decline in HIV infection among young men in Thailand. New England Journal of Medicine, 335, 297–303.
Niruthisard, S., Roddy, R.E., & Chutivongse, S. (1991). The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa. Sexually Transmitted Diseases, 18, 1769.
Niruthisard, S., Roddy, R.E., & Chutivongse, S. (1992). Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial infections. Lancet, 339, 1371–1375.
O’Leary, A., & Wingood, G. (1999). Interventions for sexually active heterosexual women. In J.L. Peterson & R.J. DiClemente (Eds), Handbook of HIV Prevention. New York: Plenum.
Ongradi, J., Ceccherini-Nelli, L., Pistell, M., Spector, S., and Bendinelli, M. (1990). Acid sensitivity of cell-free and cell-associated HIV-I: clinical implications. AIDS Research and Human Retroviruses, 6, 1433–1436.
Padian, N.S., O’Brien, T.R., Chang, Y., Glass, S., & Francis, D.P. (1993). Prevention of heterosexual transmission of human immunodeficiency virus through couple counseling. Journal of Acquired Immune Deficiency Syndromes, 6, 1043–1048.
Pauwels, R., & De Clercq, E. (1996). Development of vaginal microbicides for the prevention of heterosexual transmission of HIV. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 11, 211–221.
Pool, R., Whitworth, J., Green, G., Mbonye, A., Harrison, S., Hart, G., & Wilkinson, J. (2000, March). Ambiguity, sexual pleasure, and the acceptability of microbicidal products in southwest Uganda. Paper presented at the Microbicides 2000 meeting, Washington, DC.
Potts, M. (2000). Thinking about vaginal microbicide testing. American Journal of Public Health, 90, 188–190. Profy, A., Sonderfan, A., Chancellor, T., & McKinlay, M. (2000, March). PRO 2000 gel: A candidate topical microbicide based on a naphthalene sulfonate polymer with antimicrobial and contraceptive properties. Paper presented at the Microbicides 2000 meeting, Washington, DC.
Ramjee, G., Meyer, L., Andrews, A., & Gouws, E. (2000, March) Acceptability of a vaginal microbicide among South African men. Paper presented at the Microbicides 2000 meeting, Washington, DC.
Ray, S., Bassett, M., Maposhere, C., Manangazira, P., Nicolette, J.D., Machekano, R., & Moyo, J. (1995). Acceptability of the female condom in Zimbabwe: Positive but malecentered responses. Reproductive Health Matters, 5, 68–79.
Roddy, R.E., Cordero, M., Cordero, C., & Fortney, J.A. (1993). A dosing study of nonoxynol-9 and genital irritation. International Journal of STD and AIDS, 4, 165–170.
Roddy, R.E., Zekeng, L., Ryan, K.A., Ubalk, M., Weir, S. S., and Wong, E.L. (1998). A controlled trial of nonoxynol-9 film to reduce male-to-female transmission of sexual transmitted diseases. The New England Journal of Medicine, 339, 504–510.
Rosenberg, M.J., & Gollub, E.L. (1992). Commentary: methods women can use that may prevent sexually transmitted disease, including HIV. American Journal of Public Health, 82, 1473–1478.
Rosenberg, M.J., Rojanapithayakorn, W., Feldblum, P.J., and Higgins, J.E. (1987). Effect of the contraceptive sponge on chlamydial infection, gonorrhea, and candidiasis: a comparative clinical trial. Journal of the American Medical Association, 257, 2308–2312.
Ruminjo, J.K., Steiner, M., Joanis, C., Mwathe, E.G., & Thagana, N. (1996). Preliminary comparison of the polyurethane female condom with the latex male condom in Kenya. East African Medical Journal, 73, 101–106.
Rustomjee, R., Abdool Karim, Q.A., Abdool Karim, S., Laga, M., & Stein, Z. (1999). Phase 1 trial of nonoxynol-9 film among sex workers in South Africa. AIDS, 13, 1511–1515.
Sakondhavat, C. (1990). The female condom [Letter]. American Journal of Public Health, 80, 498.
Sakondhavat, C., & Potter, L. (1990). Further testing of female condoms [Letter]. British Journal of Family Planning, 15, 129–130.
Saracco A., Musicco M., Nicolosi A., Angarano, G., Arid, C., Gavazzeni, G., Costigliola, P., Gafa, S., Gervasoni, C., Luzzati, R., Piccinino, F., Puppo, F., Salassa, B., Sinicco, A., Stellini, R., Tirelli, U., Turbessi, G., Vigevani, G.M., Visco, G., Zerboni, R., & Lazzarin, A. (1993). Man-to-woman sexual transmission of HIV; longitudinal study of 343 steady partners of infected men. Journal of Acquired Immune Deficiency Syndrome, 6, 497–502.
Scarlett, M., Macaluso, M., & Duerr (1997, May). Acceptability of microbicides among women attending a sexually transmitted disease clinic in Alabama [Abstract]. National Conference on Women and HIV (Abstract No. P1. 13).
Shervington, D.O. (1993). The acceptability of the female condom among low-income African-American women. Journal of the National Medical Association, 85, 341–347.
Sikkema, K.,J., Heckman, T.,G., Kelly, J., A., Anderson, E.S., Winett, R.A., Solomon, L.J., Wagstaff, D.A., Roffman, R.A., Perry, M.J., Cargill, V., Crumble, D.A., Fuqua, R.W., Norman, A.D., & Mercer, M.B. (1995). HIV risk behaviors among women living in low-income, inner city housing developments. American Journal of Public Health. 86, 1123–1128.
Sinpisut, P., Chandeying, V. Skov, S., and Uahgowitchai, C. (1998). Perceptions and acceptability of the female condom [Femidom] amongst commercial sex worker in the Songkla province, Thailand Internation Journal of STD & AIDS, 9, 168–172.
Sly, D. F., Quadagno, D., Harrison, D. F., Eberstein, I.W., Riehman, K., & Bailey, M. (1997). Factors associated with the use of the female condom. Family Planning Perspectives, 29, 181–184.
Soper, D.E., Brockwell, N.J., & Dalton, H.P. (1991). Evaluation of the effects of a female condom on the female lower genital tract. Contraception, 44, 21–29.
Soper, D.E., Shoupe, D., Shangold, G., A., Shangold, M.M., Gutmann, J., & Mercer, L. (1993). Prevention of vaginal trichomoniasis by compliant use of the female condom. Sexually Transmitted Diseases, 20, 137–139.
Srirak, N., Sirirojn, B., Wichajam, M., Rugpao, S., Nelson, K., Celentano, D.D., & Khamboonruang, C. (2000, March). Acceptability of Thai males toward Buffergel as a vaginal microbicide in Chiang Mai, Thailand. Paper presented at the Microbicides 2000 meeting, Washington, DC.
Stein, Z.A. (1990). HIV prevention: the need for methods women can use. American Journal of Public Health, 80, 460–462.
Stein, Z., Saez, H., El-Sadr, W., Healton, C., Mannheimer, S., Messeri, P., Scimeca, M.M., Van Devanter, N., Zimmerman, R., & Betne, P. (1999). Safer sex strategies for women: the hierarchical model in methadone treatment clinics. Journal of Urban Health, 78, 62–72.
Stewart, F. (1998). Vaginal Barriers. In R. Hatcher, J. Trussell, F. Stewart, W. Gates, G. Stewart, F. Guest, & D. Kowal (Eds.), Contraceptive Technologies (pp. 371–404). New York: Ardent Media, Inc.
Stone, A., & Hitchcock, P. (1994). Vaginal microbicides for preventing the sexual transmission of HIV. AIDS, 8, S285–293.
The Population Council & International Family Health (2000). The case for microbicides: A global priority. New York: Author.
The Voluntary HIV-1 Counseling and Testing Efficacy Study Group (2000). Efficacy of Voluntary HIV-1 counseling and testing individuals and couples in Kenya, Tanzania and Trinidad: a randomised trial. The Lancet, 356, 103–112.
Trussell, J., Strickler, J., & Vaughan, B. (1993). Contraceptive efficacy of the diaphragm, sponge and cervical cap. Family Planning Perspectives, 26, 66–72.
Trussell, J., Sturgen, K., Strickler, J., & Dominik, R. (1994). Comparative Contraceptive Efficacy of The Female Condom and Other Barrier Methods. Family Planning Perspectives, 26, 66–72.
Van Damme, L. (2000, July). Advances in topical microbicides. Plenary presented at the 13th International Conference on AIDS. Durban, South Africa.
Van Damme, L., Niruthisard, S., Atisook, R., Boer, K, Dally, L., Laga, M., Lange, J., Karam, M., & Perriens, J.H. (1998). Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection. AIDS, 12, 433–437.
van de Wijgert, J., Nelson, K., Fullem, A., Kumwenda, N., Mehendale, S., Rugpao, S., Joglekar, N., Taha, T., Bellinger, R., Padian, N., Heagerty, P., Kelly, C., & Rosenberg, Z. (2000, March). Safety results of a multi-site international Phase I trial of the topical microbicide Buffergel. Paper presented at the Microbicides 2000 meeting, Washington, DC.
Visness, C.M., Ulin, P., Pfannenschmidt, S., & Zekeng, L. (1998). Views of Cameroonian sex workers on a woman-controlled method of contraception and disease protection. International Journal of STD & AIDS, 9, 695–699.
Voeller, B., Coulter, S.L., & Mayhan, K.G., (1991). Gas, dye, and viral transport through polyurethane condoms [Letter to the Editor]. Jounal of the American Medical Association, 266, 2986–2987.
Walker, C. K., Hitti, J., Nsubuga, P. S. J., Sembajwe, V., Katende, S., & Mbidde, E. D. (1993, June). Condom use among STD patients in Uganda [Abstract]. Ninth International Conference on AIDS (Abstract No. WS-C14-2).
Wasserheit, J.N. (1992). Epidemiological synergy: interrelationships between HIV infection and other STDs. In L. Chen, J. Sepulveda, & S. Segal, (Eds.), AIDS and Women’s Health: Science for Policy and Action (pp. 42–72). New York: Plenum Press.
Watts, C., Thompson, W., & Heise, L. (1998). The effectiveness of microbicides for HIV prevention. [Meeting Abstract]. International Conference on AIDS, (Abstract No. 33161).
Wawer, M.J., Gray, R.H., Sewankambo, N.K., Serwadda, D., Paxton, L., Berkley, S., McNairn, D., Wabwire-Mangen, F., Li C., Nalugoda, F., Kiwankua, N., Lutalo, T., Brookmeyer, R., Kelly, R., & Quinn, T.C. (1998). A randomized community trial of intensive sexually transmitted disease control for AIDS prevention, Rakai, Uganda. AIDS, 12, 1211–1225.
Weir, S. W., Feldblum, P.J., Zekeng, L., & Roddy, R. (1994). The use of nonoxynol-9 for protection against cervical gonorrhea. American Journal of Public Health, 84, 910–914.
Weller, S., C. (1993). A meta analysis of condom effectiveness in reducing sexually transmitted HIV. Social Science & Medicine, 36, 1635–44.
Witte, S. S., el-Bassel, N, Wada, T., Gray, O., & Wallace, J. (1999). Acceptability of female condom use among women exchanging street sex in New York City. International Journal of STD & AIDS, 10, 162–168.
Xu, J. X., Leeper, M.A., Wu, Y., Zhou, X.B., Xu, S.Y., Chen, T., Yang, X.L., & Zhuang, L.Q. (1998). User acceptability of a female condom (Reality) in Shanghai. Advances in Contraception, 14, 193–199.
Young, N.L., Chaowanachan, T., Wasinrapee, P., Borchardt, K.A., Elias, C., Mastro, T.D., & Kilmarx, P.H. (2000, March). In vitro effect of microbicide PC-515 and placebo gels on gen-probe pace 2 and COBAS amplicor chlamydia trachomatis and neisseria gonorrhoeae tests, and on inpouch TV trichomonas vaginalis growth. Paper presented at the Microbicides 2000 meeting, Washington, DC.
Zekeng, L., Feldblum, P.J., Oliver, R.M., & Kaptue, L. (1993). Barrier contraceptive use and HIV infection among high-risk women in Cameroon. AIDS, 7, 725–731.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Moore, J.S., Rogers, M. (2002). Female-Controlled Prevention Technologies. In: O’Leary, A. (eds) Beyond Condoms. Springer, Boston, MA. https://doi.org/10.1007/0-306-47518-9_3
Download citation
DOI: https://doi.org/10.1007/0-306-47518-9_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46731-8
Online ISBN: 978-0-306-47518-4
eBook Packages: Springer Book Archive